<DOC>
	<DOCNO>NCT02604017</DOCNO>
	<brief_summary>This study seek evaluate efficacy safety ABT-493/ABT-530 participant Genotype 1 hepatitis C virus infection without cirrhosis</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety ABT-493/ABT-530 Subjects With Genotype 1 Infection</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>1 . Male female , least 18 year age time screen . 2 . Screening laboratory result indicate HCV GT1 infection . 3 . Chronic HCV infection . 4 . Subject must HCV treatmentnaïve ( i.e. , patient never receive single dose approve investigational regimen ) treatmentexperienced ( failed prior IFN pegIFN without RBV , SOF plus RBV without pegIFN therapy ) . 5 . Subjects must noncirrhotic . Additional Inclusion Criteria GT1 HCV/HIV1 coinfected patient : 6 . HIV1 ART naïve CD4 ≥ 500 cells/mm3 ( CD4+ % ≥ 29 % ) Screening plasma HIV1 RNA &lt; 1,000 copies/mL Screening least 12 month prior Screening . Or On stable , qualify HIV1 ART regimen least 8 week prior screen , CD4 ≥ 200 cells/mm3 ( CD4+ % ≥14 % ) Screening plasma HIV1 RNA &lt; LLOQ Screening least 12 month prior Screening . 1 . History severe , lifethreatening significant sensitivity excipients study drug . 2 . Female pregnant , plan become pregnant study breastfeeding ; male whose partner pregnant planning become pregnant study . 3 . Recent ( within 6 month prior study drug administration ) history drug alcohol abuse could preclude adherence protocol opinion investigator . 4 . Positive test result Screening hepatitis B surface antigen ( HBsAg ) . 5 . HCV genotype perform screen indicate coinfection one HCV genotype . 6 . Chronic human immunodeficiency virus , type 2 ( HIV2 ) infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>HCV GT1</keyword>
	<keyword>Non-cirrhotic</keyword>
	<keyword>RBV Free</keyword>
	<keyword>Without cirrhosis</keyword>
	<keyword>Chronic Hepatitis C</keyword>
	<keyword>Hepatitis C Genotype 1 ( GT1 )</keyword>
	<keyword>IFN free</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>Ribavirin Free</keyword>
	<keyword>Interferon ( IFN ) Free</keyword>
	<keyword>HCV</keyword>
	<keyword>Hepatitis C virus</keyword>
	<keyword>DAA</keyword>
</DOC>